Nov 14, 2022 11:10am EST P3 Health Partners Provides Third-Quarter and Year-to-Date 2022 Financial Results
Nov 02, 2022 9:00am EDT P3 Health Partners Announces Participation in Credit Suisse Healthcare Conference
Oct 27, 2022 8:30am EDT P3 Health Partners Announces Nasdaq’s Confirmation that it has Regained Compliance with Listing Requirements
Oct 20, 2022 4:14pm EDT P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results; Increases 2022 Revenue Outlook
Oct 20, 2022 4:05pm EDT P3 Health Partners Announces Chief Financial Officer Transition Appoints Erin Darakjian as Interim CFO
Oct 04, 2022 4:30pm EDT P3 Health Partners Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Sep 21, 2022 8:00pm EDT P3 Health Partners CEO Dr. Sherif Abdou to Speak at Nephron 2nd Annual Physician Enablement Symposium